About MediVed
MediVed is a company based in Bengaluru (India) founded in 2006 by Dinesh Puri. It operates as a B2B. MediVed has raised $5 million across 1 funding round from investors including Trivitron. MediVed operates in a competitive market with competitors including AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
- Headquarter Bengaluru, India
- Founders Dinesh Puri
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Medived Innovations Private Limited
- Date of Incorporation 27 Feb, 2007
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$545.3 (USD)-99.17as on Mar 31, 2018
-
Net Profit
-$106.17 K (USD)39.44as on Mar 31, 2018
-
EBITDA
-$52.56 K (USD)67.07as on Mar 31, 2018
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series B
Nov 02, 2010
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MediVed
MediVed has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series B round of $5 million completed in November 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MediVed
MediVed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Trivitron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical devices for multiple therapeutic areas are manufactured through R&D.
|
Locked | Locked | Locked |
Investor details for MediVed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MediVed
Investment portfolio details for MediVed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MediVed
Detailed financials for MediVed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medived Comparisons
Peer comparison for MediVed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MediVed
MediVed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| Locked | Locked | Locked |
Trans-septal implants for atrial fibrillation treatment are developed.
|
Detailed competitors of MediVed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medived
Complete news archive for MediVed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MediVed
MediVed was founded in 2006 and raised its 1st funding round 4 years after it was founded.
MediVed is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Dinesh Puri is the current CEO of MediVed . They have also founded this company.
MediVed is a funded company, having raised a total of $5M across 1 funding round to date.
Annual revenue of MediVed is $545.3 as on Mar 31, 2018.
MediVed specializes in the design, development, and manufacturing of implantable medical devices, focusing on providing healthcare solutions, developing medical devices, implantable devices, and producing manufactured goods. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
MediVed 's top competitors include AtaCor Medical, AtriCure and CardioFocus.
MediVed has 1 investor. Key investors include Trivitron.